Specific aspects of immunotherapy for multiple sclerosis in switzerland—a structured commentary, update

HIGHLIGHTS

• who: Christoph Friedli and collaborators from the Department of Neurology, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland have published the research work: Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerlandu2014A Structured Commentary, Update, in the Journal: (JOURNAL) of 23/05/2022
• what: The authors propose a close interaction with a specialized centre.

SUMMARY

In recent years, the number of available disease-modifying therapies for multiple_sclerosis (MS) has continued to increase. To new therapies for relapsing forms of the disease, a novel treatment option has been approved for . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.